tm logo
Trademark Search
SIEVU

View On IC.GC.CA

SIEVU
REGISTERED

on 12 Nov 2020

Last Applicant/ Owned by

ELI LILLY AND COMPANY

Lilly Corporate CenterIndianapolis, IN 46285

US

Serial Number

1883831 filed on 19th Feb 2018

Registration Number

TMA1087518 registered on 12th Nov 2020

Registration expiry Date

12th Nov 2030

Correspondent Address

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

SIEVU

Trademark usage description

pharmaceutical preparations namely pharmaceutical preparations for the treatment of alzheimer's disease, anxiety disorders, atopic dermatitis, autoimm Read More

Classification Information

Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification kind code

11

Mark Details

Serial Number

1883831

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 23rd Apr 2020		Registration Pending
Submitted for opposition 191
on 23rd Apr 2020		Registration Fee Notice Sent
Submitted for opposition 42
on 29th Jan 2020		Advertised
Submitted for opposition 26
on 14th Jan 2020		Approved
Submitted for opposition 27
on 14th Jan 2020		Approval Notice Sent
Submitted for opposition 22
on 14th May 2019		Search Recorded
Submitted for opposition 20
on 14th May 2019		Examiner's First Report
Submitted for opposition 31
on 21st Feb 2018		Formalized
Submitted for opposition 1
on 20th Feb 2018		Created
Submitted for opposition 30
on 19th Feb 2018		Filed